Stock Events

Stock Events

BG Medicine

€0

0

+€0+0% Today

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

-

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RBM1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Abbott Laboratories

Abbott Laboratories competes with BG Medicine in the diagnostics and medical device sector, particularly in cardiovascular and metabolic health diagnostics.

ResMed Inc. is a competitor due to its involvement in developing medical devices and software for diagnosing, treating, and managing sleep apnea, COPD, and other chronic diseases, overlapping with BG Medicine's focus areas.

Danaher Corporation operates in the life sciences and diagnostics sector, directly competing with BG Medicine in the development of diagnostic tests and products.

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, making it a competitor in the diagnostics field.

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. competes with BG Medicine through its comprehensive range of diagnostics and research products, including technologies for disease detection.

Hologic, Inc. is focused on diagnostics, medical imaging systems, and surgical products for women's health, competing in the diagnostics market alongside BG Medicine.

Guardant Health

Guardant Health, Inc. specializes in liquid biopsies and cancer diagnostics, competing with BG Medicine in the broader diagnostics market.

QIAGEN N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market.

DexCom, Inc. specializes in glucose monitoring systems for diabetes management, competing with BG Medicine in the broader market for medical diagnostics and monitoring technologies.

About

BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.

Show more...

CEO

Mr. Stephen P. Hall

Employees

5

Country

United States

ISIN

US08861T2069

Listings

0 Comments

Share your thoughts

FAQ

What is BG Medicine stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange BG Medicine stocks are traded under the ticker RBM1.STU.

How many employees does BG Medicine have?▼

As of April 20, 2026, the company has 5 employees.

In which sector is BG Medicine located?▼

BG Medicine operates in the Health & Wellness sector.

When did BG Medicine complete a stock split?▼

BG Medicine has not had any recent stock splits.

Where is BG Medicine headquartered?▼

BG Medicine is headquartered in Waltham, United States.